To audit compliance and variation in management of neonatal respiratory distress syndrome (RDS) in an era post publication of the 2007 European Consensus Guidelines.
Background and aims:
To audit compliance and variation in management of neonatal respiratory distress syndrome (RDS) in an era post publication of the 2007 European Consensus Guidelines. infants between 34 to < 37 weeks. Prophylactic surfactant was administered in 58% of infants between 27 to < 30 weeks age group. This did not correlate with the use or non-use of prenatal steroids. Only 1 of 29 infants < 27 weeks was immediately extubated post-surfactant. Timing of surfactant re-dosing was variable and initiated at a higher mean FiO 2 66% and alveolar-arterial ratio 0.14 in prohylaxed infants < 27 weeks compared to rescue/re-dosing surfactant at mean FiO 2 48% in infants between 27 to < 30 weeks.
Methodology

Conclusions:
Overall compliance was achieved in prophylactic surfactant administration in infants < 27 weeks. For babies more than 27 weeks, significant variation was demonstrated in management strategies. This practice variation prompts generation of a unit policy of when to intervene with progression of RDS.
